Xalatan

Xalatan is a brand name of latanoprost ophthalmic, approved by the FDA in the following formulation(s):

XALATAN (latanoprost - solution/drops; ophthalmic)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: June 5, 1996
  
  Strength(s): 0.005% ^[RLD][AT]

Has a generic version of Xalatan been approved?

Yes. The following products are equivalent to Xalatan:

latanoprost solution/drops; ophthalmic

• 
  Manufacturer: ALCON RES
  
  Approval date: March 22, 2011
  
  Strength(s): 0.005% ^[AT]


• 
  Manufacturer: APOTEX
  
  Approval date: March 22, 2011
  
  Strength(s): 0.005% ^[AT]


• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: March 22, 2011
  
  Strength(s): 0.005% ^[AT]


• 
  Manufacturer: LUITPOLD
  
  Approval date: March 22, 2011
  
  Strength(s): 0.005% ^[AT]


• 
  Manufacturer: MYLAN
  
  Approval date: March 22, 2011
  
  Strength(s): 0.005% ^[AT]


• 
  Manufacturer: PADDOCK LLC
  
  Approval date: July 19, 2011
  
  Strength(s): 0.005% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xalatan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Xalatan.

See also...

• Xalatan Consumer Information (Drugs.com)
• Xalatan Drops Consumer Information (Wolters Kluwer)
• Xalatan Consumer Information (Cerner Multum)
• Xalatan Multi-Pack Consumer Information (Cerner Multum)
• Xalatan Advanced Consumer Information (Micromedex)
• Xalatan AHFS DI Monographs (ASHP)
• Latanoprost Drops Consumer Information (Wolters Kluwer)
• Latanoprost ophthalmic Consumer Information (Cerner Multum)
• Latanoprost Ophthalmic Advanced Consumer Information (Micromedex)
• Latanoprost AHFS DI Monographs (ASHP)